Clinical Trials Logo
  1. Home
  2. Affective Disorders, Psychotic
  3. NCT01518049
  4. Details
NCT01518049 Clinical Trial

Clinical Validation of the Rating Scale for Psychotic Depression (RAS-PD)

Affective Disorders, Psychotic Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT01518049
Other study ID # N-20110029
Secondary ID
Status Completed
Phase N/A
First received January 21, 2012
Last updated October 12, 2015
Start date February 2012
Est. completion date September 2014

Study information
Verified date October 2015
Source Aarhus University Hospital
Contact n/a
Is FDA regulated No
Health authority Denmark: The Danish National Committee on Biomedical Research Ethics
Study type Observational

Clinical Trial Summary

The aim of this study is to develop a scale to measure the severity of depression with psychotic symptoms (psychotic depression). Furthermore, we hope to detect potential biomarkers (substances in the blood) which can aid in the detection of psychotic depression.

Main hypothesis: A clinically valid rating scale measuring the severity of psychotic depression can be developed.

Recruitment information / eligibility
Status Completed
Enrollment 50
Est. completion date September 2014
Est. primary completion date September 2013
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Fulfilling ICD-10 criteria DF32.3 or DF33.3

- At least 18 years old

- Legally competent

- Informed consent (oral & written)

Exclusion Criteria:

- Insufficient Danish Language skills

- Moderate to severe dementia

- Abuse of psychoactive substances

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

Locations
Country Name City State
Denmark Unit for Psychiatric Research, Aalborg Psychiatric Hospital, Aarhus University Hospital Aalborg

Sponsors (1)
Lead Sponsor Collaborator
Søren Dinesen Østergaard

Country where clinical trial is conducted

Denmark, 

References & Publications (1)

Østergaard SD, Pedersen CH, Uggerby P, Munk-Jørgensen P, Rothschild AJ, Larsen JI, Gøtzsche C, Søndergaard MG, Bille AG, Bolwig TG, Larsen JK, Bech P. Clinical and psychometric validation of the psychotic depression assessment scale. J Affect Disord. 2015 — View Citation

See also
  Status Clinical Trial Phase
Completed NCT00240721 - A Study of the Effectiveness and Safety of Topiramate in the Treatment of Patients With Bipolar Disorder Phase 3
Completed NCT02077829 - Implementation of Illness Management and Recovery in Mental Health Services N/A
Completed NCT01324973 - Web-Based Weight Management for Individuals With Mental Illness N/A
Recruiting NCT04118283 - Assessment and Treatment for Chronic Pain in Veterans With Serious Mental Illness N/A
Completed NCT00627510 - Routine Plasma Level Determination to Compare Actual vs Expected Plasma Levels at Psychiatric Inpatient Admission N/A
Recruiting NCT03919760 - Early Psychosis Intervention - Spreading Evidence-based Treatment
Completed NCT00035802 - A Study to Evaluate the Safety and Effectiveness of Topiramate Compared to Placebo in the Treatment of Patients With Bipolar I Disorder Phase 3
Completed NCT02474524 - Self-Management and Recovery Technology Psychosocial Intervention Trial N/A
Completed NCT02321943 - Anomalous Self-Experience in First Episode Psychosis - A Six-Year Follow-Up Study N/A
Terminated NCT00867360 - Treatment of Psychotic Major Depression With Mifepristone Phase 3
Completed NCT00960375 - Smoking Cessation for Veterans With Severe and Persistent Mental Illness Phase 2/Phase 3